Medical Research
(H30)
IRS Verified
DX Registered
990 on File
FOR PETES SAKE CANCER RESPITE FOUNDATION
Financial strength (30%)
78/100
Reliability (20%)
55/100
Effectiveness (25%)
86/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
For Pete’s Sake Cancer Respite Foundation enables cancer patients and their loved ones to strengthen, deepen and unify their relationships by creating unforgettable and lasting respite experiences.
Financial Overview — FY 2025
$6.8M
Total Revenue
$2.3M
Total Expenses
$13.6M
Net Assets
18
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.4%
Fundraising Efficiency
233.4%
Operating Reserve
71.09x
Liability-to-Asset
2.2%
Revenue Diversification
99.3%
Executive Compensation
$236K
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.4% | 83.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
2.7% | 9.9% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
19.0% | 2.6% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
233.4% | 110.6% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
71.1 mo | 14.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.2% | 13.2% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.3% | 90.0% |
P10P90
|
Bottom quarter |
|
Surplus margin
Surplus as a share of revenue
|
66.2% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $6.8M | $2.3M | $13.6M | 78.4% | 18 |
| 2023 | $4.7M | $2.1M | $8.4M | 73.1% | 17 |
| 2022 | $4.0M | $1.9M | $5.8M | 70.3% | 10 |
| 2021 | $1.9M | $1.1M | N/A | — | 15 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.